Click on a research project below to read more information.
Filter to narrow by different strategic priorities.
The North East Innovation Lab is part of Newcastle Hospitals NHS Foundation Trust (NuTH) and works with organisations of all sizes, from university spin outs to large international companies.
Read more
TTP is an internationally respected product and technology development firm based in Cambridge, UK. For over 35 years, clients across a spectrum of industries including health tech, life science...
Read more
General
What is the PACE Academy?
The Academy is part of PACE’s commitment to providing support as well as funding to PACE portfolio projects. The content of the academy will be tailored to the cohort of funded projects but is expected to connect innovators with a variety of stakeholders and experts, who will provide tailored support and guidance to help teams progress their assets. For example, this could include support with scientific study design, regulatory strategy or introductions to downstream funders or investors.
Can PACE provide access to any other wider enabling capabilities?
As part of PACE support, we are tackling barriers to AMR therapeutic and diagnostic development by connecting global innovators with UK national capabilities to help shape and drive projects forward. One such cross-cutting collaboration established is with the UK Health Security Agency (UKHSA) to enable early evaluation of in vitro antimicrobial activity across the PACE therapeutic portfolio. We are continually assessing the AMR ecosystem to identify additional capabilities that can strengthen delivery of our portfolio of projects and address common gaps within data packages. To find out more about enabling technologies and capabilities, please visit the Partnerships page.
What is PACE, is it just about grant funding?
PACE is a collaboration between three leaders in the UK's health innovation and research community. The £30m initiative harnesses the expertise of the partner organisations to not only grant fund projects but also to offer advice and mentorship and to provide access to a collaborative network of potential project partners to enable the best chance of project success - de-risked and investment-ready assets for potential downstream funding (by, e.g. CARB-X, corporate and venture investment and other later stage funding and support mechanisms).
Scope of the 2024 Diagnostic Innovations Funding Round
What is the PACE Catalyser?
The Catalyser is part of PACE’s commitment to strengthening the AMR research ecosystem by providing support to applicants that are selected to submit Full Applications following the EOI stage. The support provided will be aimed at helping development of Full Applications and, as part of this, shaping projects with maximum potential to deliver de-risked and investment-ready assets for onward development.
What is the role of the PACE R&D Advisor?
PACE R&D Advisors will actively engage with you and your project team throughout the lifecycle of the project (including helping develop the full application). Support will be tailored to individual project needs (defined at the full application stage). Support may include signposting and making connections across the PACE delivery partner network and beyond as needed; mentorship and advice including but not limited to drug/diagnostic discovery, disease area insight, experimental work package design and support to engage 3rd party delivery partners as needed (e.g. development of a statement of works and acting as the point of contact); facilitating scientific advisory boards and public and patient engagement panels. PACE R&D Advisors will not make funding decisions about your project, but they will be involved in reporting on project progress to the PACE joint programme management board.
What is the PACE Delivery Partner Network, how do I access it and do I have to use it?
PACE has brought together a network of delivery partners to enable all aspects of outsourced project work across the PACE-funded project portfolio. PACE recognises that not all applicants will have the internal resources and pre-existing relationships required for end-to-end project delivery and, for that reason, wants to be able to facilitate connections and collaborations. Recipients of PACE Project Awards will retain the right to choose whom they work with to deliver their project, including where the Recipient has established relationships with their own delivery partners. PACE R&D Advisors will work closely with Recipients of funding to identify where access to a PACE delivery partner is in the best interests of the project.